TD Asset Management’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
TD Asset Management's DNTH Position: Q3 2026 in Review
TD Asset Management reduced its Dianthus Therapeutics (DNTH) stake by 9.2% in Q3 2026, selling an estimated $2.15M and leaving 204,628 shares worth $17.8M. The position accounts for 0.02% of the portfolio, ranked #527.
TD Asset Management first reported a position in DNTH in Q3 2025 and has held it in 5 quarters since. The position peaked at $22M in Q2 2026. 275 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.
- TD Asset Management held 204,628 shares of Dianthus Therapeutics worth $17.8M as of Q3 2026.
- TD Asset Management sold 20,706 Dianthus Therapeutics shares in Q3 2026, an estimated $2.15M.
- Dianthus Therapeutics made up 0.02% of TD Asset Management's portfolio in Q3 2026, its #527 holding.
- TD Asset Management first reported a position in Dianthus Therapeutics in Q3 2025 and has held it in 5 quarters since.
- TD Asset Management's Dianthus Therapeutics position peaked at $22M in Q2 2026.
- 275 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.
Based on TD Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.